| (CNY) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 2.02B | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 600535.SS returned -11.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -1.1% |
| 1 year | -11.6% |
| 5 years | +28.4% |
| 10 years | -34.7% |
| All-time high | ¥39.42 (May 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what ¥1,000 in 600535.SS would be worth today ›Yes. Tasly Pharmaceutical Group Co., Ltd paid 2 dividends over the past 12 months. The most recent was ¥0.10 per share on May 29, 2026. The dividend yield is 2.09%.
Tasly Pharmaceutical Group Co., Ltd is part of the Healthcare sector.
Tasly Pharmaceutical Group Co., Ltd has a market cap of 22.11B CNY, based on the latest quote.
